Investing
Also, Roche and Astellas have combined their diabetes management solutions.
GV, Thrive Capital and Salesforce Ventures led the company's seed funding round.
The startup previously raised $14 million in 2020.
The company will use the funds to continue its growth in the U.S.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
It also received backing from the founding members of Grab and Zalora.
Blood-collection device-maker Vitestro, tech-enabled baby bottle designer Emulait, digital health support platform Reveal HealthTech and AI-based testing platform PocDoc also received funding.
It now plans to release more hypnosis-based DTx apps for anxiety, sleep, and chronic pain.
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.